“Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model”. 2025. International Journal of Environmental Sciences 11 (12s): 1360-67. https://doi.org/10.64252/8crhea08.